Oncocyte Total Current Liabilities

Oncocyte (OCX) currently reports a total current liabilities of $12M as of March 2026. That compares with $9.7M in the prior-year period — up 24.0% year over year. Use the charts on this page to explore Oncocyte's total current liabilities history and peer comparisons.

Oncocyte's total current liabilities increased from $9.7M to $12M — a 24.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Oncocyte reported $12M in total current liabilities as of March 2026. That compares with $9.7M in the prior-year period — up 24.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Oncocyte, and consider following OCX for alerts when major investors trade the stock.

Oncocyte is classified in the Technology sector. On total current liabilities, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing OCX with unrelated industries.